Literature DB >> 18617305

Relations of measures of endothelial function and kidney disease: the Framingham Heart Study.

Meredith C Foster1, Michelle J Keyes, Martin G Larson, Joseph A Vita, Gary F Mitchell, James B Meigs, Ramachandran S Vasan, Emelia J Benjamin, Caroline S Fox.   

Abstract

BACKGROUND: Endothelial dysfunction is prevalent in individuals with end-stage renal disease. Whether endothelial dysfunction is present in patients with moderate chronic kidney disease (CKD) is uncertain. STUDY
DESIGN: Cross-sectional study. SETTINGS & PARTICIPANTS: Brachial reactivity measurements were obtained during the seventh examination cycle in 2,818 (diameter measurements) and 2,256 (flow measurements) Framingham Heart Study Offspring cohort participants (53% women; mean age, 61 +/- 9 years). PREDICTOR: Estimated glomerular filtration rate less than 60 mL/min/1.73 m(2) derived from creatinine- and cystatin C-based estimating equations; microalbuminuria status. OUTCOME: Brachial reactivity measurements (baseline brachial diameter, flow-mediated dilation, baseline and hyperemic mean flow). MEASUREMENTS: Linear regression models were used to model brachial measures as a function of CKD and microalbuminuria status.
RESULTS: Overall, 7.3% (n = 206) of participants had CKD, and of 2,301 with urinary measurements, 10.0% (n = 230) had microalbuminuria. Brachial reactivity measures did not differ significantly by CKD status in either creatinine- or cystatin C-based equations in either age- and sex- or multivariable-adjusted models. In age- and sex-adjusted models, microalbuminuria was associated with decreased hyperemic mean flow (47.2 +/- 1.4 versus 51.4 +/- 0.5 mg/g; P = 0.005), but the association was not significant after multivariable adjustment (P = 0.09). LIMITATIONS: Predominantly white ambulatory cohort; results may not be generalizable to other ethnic groups or individuals with severe CKD.
CONCLUSIONS: Endothelial dysfunction was not a major correlate of CKD in our sample.

Entities:  

Mesh:

Year:  2008        PMID: 18617305      PMCID: PMC2665728          DOI: 10.1053/j.ajkd.2008.04.027

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  49 in total

1.  Endothelial function: a barometer for cardiovascular risk?

Authors:  Joseph A Vita; John F Keaney
Journal:  Circulation       Date:  2002-08-06       Impact factor: 29.690

2.  Local shear stress and brachial artery flow-mediated dilation: the Framingham Heart Study.

Authors:  Gary F Mitchell; Helen Parise; Joseph A Vita; Martin G Larson; Elaine Warner; John F Keaney; Michelle J Keyes; Daniel Levy; Ramachandran S Vasan; Emelia J Benjamin
Journal:  Hypertension       Date:  2004-07-12       Impact factor: 10.190

3.  Predictors of new-onset kidney disease in a community-based population.

Authors:  Caroline S Fox; Martin G Larson; Eric P Leip; Bruce Culleton; Peter W F Wilson; Daniel Levy
Journal:  JAMA       Date:  2004-02-18       Impact factor: 56.272

4.  Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study.

Authors:  Alfred K Cheung; Mark J Sarnak; Guofen Yan; Michael Berkoben; Robert Heyka; Allen Kaufman; Julia Lewis; Michael Rocco; Robert Toto; David Windus; Daniel Ornt; Andrew S Levey
Journal:  Kidney Int       Date:  2004-06       Impact factor: 10.612

5.  Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study.

Authors:  Emelia J Benjamin; Martin G Larson; Michelle J Keyes; Gary F Mitchell; Ramachandran S Vasan; John F Keaney; Birgitta T Lehman; Shuxia Fan; Ewa Osypiuk; Joseph A Vita
Journal:  Circulation       Date:  2004-02-10       Impact factor: 29.690

6.  Cardiovascular risk factors in predialysis patients: baseline data from the Chronic Renal Impairment in Birmingham (CRIB) study.

Authors:  David C Wheeler; John N Townend; Martin J Landray
Journal:  Kidney Int Suppl       Date:  2003-05       Impact factor: 10.545

7.  Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study.

Authors:  Martin J Landray; David C Wheeler; Gregory Y H Lip; David J Newman; Andrew D Blann; Fiona J McGlynn; Simon Ball; John N Townend; Colin Baigent
Journal:  Am J Kidney Dis       Date:  2004-02       Impact factor: 8.860

8.  Forearm reactive hyperemia and mortality in end-stage renal disease.

Authors:  Gérard M London; Bruno Pannier; Mohsen Agharazii; Alain P Guerin; Francis H M Verbeke; Sylvain J Marchais
Journal:  Kidney Int       Date:  2004-02       Impact factor: 10.612

Review 9.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Circulation       Date:  2003-10-28       Impact factor: 29.690

10.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.

Authors:  Josef Coresh; Brad C Astor; Tom Greene; Garabed Eknoyan; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2003-01       Impact factor: 8.860

View more
  10 in total

1.  Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Ruth Dubin; Michael Shlipak; Yongmei Li; Joachim Ix; Ian H de Boer; Nancy Jenny; Carmen A Peralta
Journal:  Nephrol Dial Transplant       Date:  2010-11-15       Impact factor: 5.992

2.  Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study.

Authors:  Ruth Dubin; Yongmei Li; Joachim H Ix; Michael G Shlipak; Mary Whooley; Carmen A Peralta
Journal:  Am Heart J       Date:  2012-02       Impact factor: 4.749

3.  Association of pulse pressure, arterial elasticity, and endothelial function with kidney function decline among adults with estimated GFR >60 mL/min/1.73 m(2): the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Carmen A Peralta; David R Jacobs; Ronit Katz; Joachim H Ix; Magdalena Madero; Daniel A Duprez; Mark J Sarnak; Michael H Criqui; Holly J Kramer; Walter Palmas; David Herrington; Michael G Shlipak
Journal:  Am J Kidney Dis       Date:  2011-10-14       Impact factor: 8.860

4.  Neither proteinuria nor albuminuria is associated with endothelial dysfunction in HIV-infected patients without diabetes or hypertension.

Authors:  Samir K Gupta; Changyu Shen; Kieren J Mather; Rajiv Agarwal; Michael P Dubé
Journal:  J Infect Dis       Date:  2011-10-19       Impact factor: 5.226

5.  Arterial stiffness in mild-to-moderate CKD.

Authors:  Ashish Upadhyay; Shih-Jen Hwang; Gary F Mitchell; Ramachandran S Vasan; Joseph A Vita; Plamen I Stantchev; James B Meigs; Martin G Larson; Daniel Levy; Emelia J Benjamin; Caroline S Fox
Journal:  J Am Soc Nephrol       Date:  2009-07-16       Impact factor: 10.121

6.  Correlation between arterial stiffness and inflammatory markers in autosomal dominant polycystic kidney disease patients with preserved renal function.

Authors:  Cuma Bulent Gul; Abdulmecit Yildiz; Alparslan Ersoy; Serdar Kahvecioglu; Burak Asiltas; Fatih Yildirim; Selime Ermurat; Saim Sag; Aysegul Oruc; Sumeyye Gullulu; Mustafa Gullulu
Journal:  Int Urol Nephrol       Date:  2015-06-06       Impact factor: 2.370

7.  Association between urinary albumin excretion and coronary heart disease in black vs white adults.

Authors:  Orlando M Gutiérrez; Yulia A Khodneva; Paul Muntner; Dana V Rizk; William M McClellan; Mary Cushman; David G Warnock; Monika M Safford
Journal:  JAMA       Date:  2013-08-21       Impact factor: 56.272

8.  Vascular Dysfunction, Oxidative Stress, and Inflammation in Chronic Kidney Disease.

Authors:  Kristen L Nowak; Anna Jovanovich; Heather Farmer-Bailey; Nina Bispham; Taylor Struemph; Mikaela Malaczewski; Wei Wang; Michel Chonchol
Journal:  Kidney360       Date:  2020-06-25

Review 9.  Is the presence of microalbuminuria a relevant marker of kidney disease?

Authors:  Richard J Glassock
Journal:  Curr Hypertens Rep       Date:  2010-10       Impact factor: 5.369

10.  Albuminuria and Diabetic Retinopathy in Type 2 Diabetes Mellitus Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 12).

Authors:  Padmaja K Rani; Rajiv Raman; Aditi Gupta; Swakshyar S Pal; Vaitheeswaran Kulothungan; Tarun Sharma
Journal:  Diabetol Metab Syndr       Date:  2011-05-25       Impact factor: 3.320

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.